Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era
Dados Bibliográficos
| ID | 9105078 |
|---|---|
| Autores | Shashi N Kapadia (0000-0001-6363-2839, Division of Infectious Diseases, autor correspondente), Phyllis Johnson (0000-0002-8594-9041, Weill Cornell Medicine), Kristen M Marks (Division of Infectious Diseases), Kristen Marks (0000-0003-1896-4978, Office of Infectious Diseases, autor correspondente), Bruce R Schackman (0000-0002-1132-2932, Weill Cornell Medicine), Yuhua Bao (0000-0002-3825-4327, Weill Cornell Medicine) |
| Ano | 2021 |
| Volume | 59 |
| Fascículo | 9 |
| Páginas | 795-800 |
| Data de publicação | 2021-09-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | Medical Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000001573 |
| PMID | 34081676 |
| OpenAlex | W3164240098 |
| Idioma | EN |
| Referências citadas | 26 |
BACKGROUND: Hepatitis C virus (HCV) remains under-treated in the United States and treatment by nonspecialist providers can expand access. We compare HCV treatment provision and treatment completion between nonspecialist and specialist providers. METHODS: This retrospective study used claims data from the Healthcare Cost Institute from 2013 to 2017. We identified providers who prescribed HCV therapy between 2013 and 2017, and patients enrolled in private insurance or Medicare Advantage who had pharmacy claims for HCV treatment. We measured HCV treatment completion, determined based on prescription fills for the minimum expected duration of the antiviral regimen. Using propensity score-weighted regression, we compared the likelihood of early treatment discontinuation by the type of treating provider. RESULTS: The number of providers prescribing HCV treatment peaked in 2015 and then declined. The majority were gastroenterologists, although the proportion of general medicine providers increased to 17% by 2017. Among the 23,463 patients analyzed, 1008 (4%) discontinued before the expected minimum duration. In the propensity score-weighted analysis, patients treated by general medicine physicians had similar odds of treatment discontinuation compared with those treated by gastroenterologists [odds ratio (OR)=1.00, 95% confidence interval (CI): 0.99-1.01, P=0.45]. Results were similar when comparing gastroenterologists to nonphysician providers (OR=1.00, 95% CI: 0.99-1.01, P=0.53) and infectious diseases specialists (OR=1.00, 95% CI: 0.99-1.01, P=0.71). CONCLUSIONS: HCV treatment providers remain primarily gastroenterologists, even in the current simplified treatment era. Patients receiving treatment from general medicine or nonphysician providers had a similar likelihood of treatment completion, suggesting that removing barriers to the scale-up of treatment by nonspecialists may help close treatment gaps for hepatitis C
Discontinuation · Family medicine · Hepatitis C · Hepatitis C virus · Medical prescription · Odds ratio · Propensity score matching · Regimen · Retrospective cohort study · Virus · Diabetes Management and Education · Hepatitis C virus research · Immunology · Internal Medicine · Medication Adherence and Compliance · Medicine · Pharmacy
Doubly Robust Estimation in Missing Data and Causal Inference Models
Methods for Constructing and Assessing Propensity Scores
A tutorial on propensity score estimation for multiple treatments using generalized boosted models
Propensity Score Estimation With Boosted Regression for Evaluating Causal Effects in Observational Studies.
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City
Public Health Detailing of Primary Care Providers
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |